Optimisation of expression of parvoviral rep and cap proteins in insect cells

Details for Australian Patent Application No. 2009215987 (hide)

Owner Amsterdam Molecular Therapeutics B.V.

Inventors Hermens, Wilhelmus Theodorus Johannes Maria Christiaan; Noordman, Yvet; Bakker, Andrew Christian

Agent Freehills

Pub. Number AU-A-2009215987

PCT Pub. Number WO2009/104964

Priority 08151634.6 19.02.08 EP; 61/029,673 19.02.08 US

Filing date 19 February 2009

Wipo publication date 27 August 2009

International Classifications

C12N 7/04 (2006.01) Viruses, e.g. bacteriophages - Inactivation or attenuation

C07K 14/015 (2006.01) Peptides having more than 20 amino acids

C12N 5/07 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells or tissues

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

C12N 15/864 (2006.01) Mutation or genetic engineering - Parvoviral vectors

Event Publications

16 September 2010 PCT application entered the National Phase

  PCT publication WO2009/104964 Priority application(s): WO2009/104964

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009215991-Intrusion detection system with signal recognition

2009215973-Intelligent firearm locking device